# Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

> **NCT01561469** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 188 (actual)

## Conditions studied

- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Hospital-Acquired Pneumonia

## Interventions

- **DRUG:** Linezolid
- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT01561469
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2014-07-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01561469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01561469, "Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01561469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*